Cologne Cohort of Neutropenic Patients (CoCoNut)
Launched by UNIVERSITY HOSPITAL OF COLOGNE · Mar 26, 2013
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Cologne Cohort of Neutropenic Patients (CoCoNut) is a clinical study that aims to understand the risks and outcomes of patients who have weakened immune systems, particularly those with blood cancers or those receiving chemotherapy. The study will look at various factors, treatments, and the occurrence of infections that can happen in these patients. If you or a loved one is immunosuppressed—meaning your immune system is not working properly—this study may be a good fit.
Anyone aged 1 year or older who is immunosuppressed can participate in the study. There are no specific exclusions, so many patients may be eligible. Participants will not receive any new treatments as part of this study; instead, the focus is on observing and collecting information about their health over time. This research is important because it can help improve the care and support for patients with weakened immune systems in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • immunosuppressed patients
- Exclusion Criteria:
- • none
About University Hospital Of Cologne
The University Hospital of Cologne is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, collaborating with multidisciplinary teams to conduct rigorous investigations that enhance patient care and contribute to the development of new therapeutic strategies. With state-of-the-art facilities and a strong emphasis on education and training, the University Hospital of Cologne is dedicated to fostering a collaborative environment that promotes ethical research practices and improves health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cologne, North Rhine Westphalia, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials